🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This is a single center, open-label, fixed sequence Phase 1, drug-drug inte...
Status
Completed
Location
ICON Early Phase Services
Start Date
2022-04-26
Trial ID
NCT05334108
The main objective of this study is to assess the effect of DC-806 on the p...
Status
Completed
Location
ICON Phase 1 Clinic
Start Date
2023-10-16
Trial ID
NCT06092931
Treatments Being Tested
The purpose of this study is to assess the effect of multiple doses of gana...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-03-09
Trial ID
NCT05236530
This is an investigator-and-subject blind, phase 1 study to characterize th...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2015-05
Trial ID
NCT02440100
Treatments Being Tested
Non-alcoholic fatty liver disease is a chronic, serious, life-threatening, ...
Status
Not Yet Recruiting
Location
Nucleus Network Pty Ltd
Start Date
2026-07
Trial ID
NCT07726368
Treatments Being Tested
Study 516-010 is an open-label Phase 1, drug-drug interaction and QTc study...
Status
Completed
Location
Goshen Health
Start Date
2021-04-08
Trial ID
NCT04887194
Treatments Being Tested
This initial Phase I study will evaluate the dose-related safety and tolera...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2017-09-21
Trial ID
NCT03335956
Treatments Being Tested